Comparative Effectiveness of Antipsychotics in Preventing Readmission for First-Admission Schizophrenia Patients in National Cohorts From 2001 to 2017 in Taiwan

Lin, Yi-HsuanYi-HsuanLinWu, Chi-ShinChi-ShinWuCHEN-CHUNG LIUPO-HSIU KUOChan, Hung-YuHung-YuChanWEI J. CHEN2023-03-212023-03-212022-06-210586-7614https://scholars.lib.ntu.edu.tw/handle/123456789/629490Antipsychotics remain the main treatment for schizophrenia, but their effectiveness is challenging to compare. We aimed to assess the comparative real-world effectiveness of antipsychotics in preventing readmission among patients in Asia with early-stage schizophrenia to inform clinical decision making.enNational Health Insurance; hospitalization; long-acting injectable antipsychotics; mental health services; risperidone[SDGs]SDG3Comparative Effectiveness of Antipsychotics in Preventing Readmission for First-Admission Schizophrenia Patients in National Cohorts From 2001 to 2017 in Taiwanjournal article10.1093/schbul/sbac046355690042-s2.0-85132455980WOS:000795656800001https://api.elsevier.com/content/abstract/scopus_id/85132455980